🇺🇸 FDA
Patent

US 11015204

Synthesis and structure of high potency RNA therapeutics

granted A61KA61K38/012A61K38/1725

Quick answer

US patent 11015204 (Synthesis and structure of high potency RNA therapeutics) held by ARCTURUS THERAPEUTICS, INC. expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K38/012, A61K38/1725, A61K38/18, A61K38/363